Education

PhD/MD Curriculum in cooperation with the University Tuebingen

The PhD/MD curriculum complements the scientific training of the PhD/MD students in the individual research groups at the IKP and the RBCT. It consists of weekly seminars over a period of 3 years (6 semesters) covering essential content from experimental and clinical pharmacology, biochemistry, physiology, pathophysiology of selected diseases, statistics, clinical trials, ethics and law in clinical trials, and other key topics. Further, the PhD/MD curriculum also comprises aspects of career planning, technology transfer and good scientific practice. Senior scientists from the IKP, the RBK, and the RBCT give lectures according to their respective expertise. For topics for which no in-house expertise is available (e.g. technology transfer, perspectives from industry, ethics and law), external guests are invited to share their knowledge with the students.

Running Schedule

Focus on Translational Research at IKP, RBCT and RBIM

21.10.2026       D. Saul (RBCT)    The curious case of the SASP in cellular senescence and cancer
11.11.2026  H. Horn/C. Kalla/G. Ott (IKP)    PharmacoOmics & lymphoma
25.11.2026H. Yun (RBCT)    Transcription in chaos: How gene mutations fuel leukemia
02.12.2026T. Mürdter/M. Dong (IKP)    Microphysiological tissue models of solid cancer and microenvironment
16.12.2026W. Ge (RBCT)    Omics technologies and computational tools for translational research
20.01.2027V. Lauschke (IKP)    Microphysiological tissue models of metabolic disease
03.02.2027H. Cramer (RBIM)    Research in Integrative Medicine: Characteristics, patterns, methodology
10.02.2027W. Schroth/F. Büttner (IKP)    Breast cancer recurrence and clinical translation
24.02.2027S. Beyes (RBCT)    Targeting mitotic vulnerabilities in breast cancer
03.03.2027R.Tremmel/E. Schäffeler/
R. Bohnert/ M. Schwab (IKP)
    Clinical pharmacogenomics, metabolism and cancer